• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).腺苷脱氨酶缺乏症和嘌呤核苷磷酸化酶缺乏症中的淋巴细胞特异性毒性:核苷激酶的可能作用。
Proc Natl Acad Sci U S A. 1977 Dec;74(12):5677-81. doi: 10.1073/pnas.74.12.5677.
2
Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏时的脱氧核糖核苷毒性:对新型免疫抑制剂开发的启示
Ciba Found Symp. 1978(68):115-33. doi: 10.1002/9780470720516.ch8.
3
Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.与腺苷脱氨酶和嘌呤核苷磷酸化酶基因缺陷相关的不同免疫缺陷状态的可能代谢基础。
Proc Natl Acad Sci U S A. 1982 Jun;79(12):3848-52. doi: 10.1073/pnas.79.12.3848.
4
Immune deficiency due to adenosine deaminase and purine nucleoside phosphorylase deficiency: a simple diagnostic test.腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏所致免疫缺陷:一种简易诊断试验。
J Clin Pathol. 1984 Nov;37(11):1305-7. doi: 10.1136/jcp.37.11.1305.
5
Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.培养的T细胞以及腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏患者的细胞中的核苷酸代谢。
Ciba Found Symp. 1978(68):101-14. doi: 10.1002/9780470720516.ch7.
6
Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease.用于研究腺苷脱氨酶和嘌呤核苷磷酸化酶缺陷性免疫疾病的细胞培养模型的特性分析。
Cell. 1976 Oct;9(2):205-11. doi: 10.1016/0092-8674(76)90111-2.
7
Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies.遗传性酶缺乏症和免疫缺陷:腺苷脱氨酶(ADA)和嘌呤核苷磷酸化酶(PNP)缺乏症。
Clin Immunol Immunopathol. 1986 Jul;40(1):157-65. doi: 10.1016/0090-1229(86)90081-4.
8
Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏症:它们是如何被发现的以及可能意味着什么。
Ciba Found Symp. 1978(68):3-18. doi: 10.1002/9780470720516.ch2.
9
[Congenital immunodeficiency with adenosine deaminase and purine nucleoside phosphorylase deficiency].[伴有腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏的先天性免疫缺陷]
Nihon Rinsho. 1977 Aug 10;35(8):2564-80.
10
[Immune insufficiency in enzyme defects of purine metabolism].[嘌呤代谢酶缺陷中的免疫功能不全]
Z Gesamte Inn Med. 1983 Feb 1;38(3):83-9.

引用本文的文献

1
Cladribine tablets in the new multiple sclerosis era.新多发性硬化症时代的克拉屈滨片
Ther Adv Neurol Disord. 2025 Jun 19;18:17562864251342855. doi: 10.1177/17562864251342855. eCollection 2025.
2
Cladribine tablets after treatment with natalizumab (CLADRINA) - rationale and design.那他珠单抗治疗后使用克拉屈滨片(CLADRINA)——原理与设计
Ther Adv Neurol Disord. 2024 Apr 4;17:17562864241233858. doi: 10.1177/17562864241233858. eCollection 2024.
3
Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis.鞘氨醇 1 受体调节剂及其他多发性硬化症治疗药物的分子神经免疫药理学
Pharmacol Ther. 2023 Jun;246:108432. doi: 10.1016/j.pharmthera.2023.108432. Epub 2023 May 4.
4
systems to study inborn errors of immunity using human induced pluripotent stem cells.使用人类诱导多能干细胞研究先天性免疫缺陷的系统。
Front Immunol. 2022 Nov 17;13:1024935. doi: 10.3389/fimmu.2022.1024935. eCollection 2022.
5
The Use of Induced Pluripotent Stem Cells to Study the Effects of Adenosine Deaminase Deficiency on Human Neutrophil Development.利用诱导多能干细胞研究腺苷脱氨酶缺乏对人中性粒细胞发育的影响。
Front Immunol. 2021 Oct 28;12:748519. doi: 10.3389/fimmu.2021.748519. eCollection 2021.
6
Long-Term Immune Recovery After Hematopoietic Stem Cell Transplantation for ADA Deficiency: a Single-Center Experience.ADA 缺陷症造血干细胞移植后的长期免疫恢复:单中心经验。
J Clin Immunol. 2022 Jan;42(1):94-107. doi: 10.1007/s10875-021-01145-w. Epub 2021 Oct 16.
7
5-Fluorouracil in combination with deoxyribonucleosides and deoxyribose as possible therapeutic options for the Coronavirus, COVID-19 infection.5-氟尿嘧啶联合脱氧核苷和脱氧核糖作为治疗冠状病毒 COVID-19 感染的可能选择。
Med Hypotheses. 2020 Sep;142:109754. doi: 10.1016/j.mehy.2020.109754. Epub 2020 Apr 22.
8
Cladribine tablets' potential role as a key example of selective immune reconstitution therapy in multiple sclerosis.克拉屈滨片作为多发性硬化症选择性免疫重建疗法的关键范例的潜在作用。
Degener Neurol Neuromuscul Dis. 2018 May 3;8:35-44. doi: 10.2147/DNND.S161450. eCollection 2018.
9
Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review.福多司坦治疗复发/难治性外周T细胞淋巴瘤:一项基于证据的综述。
Onco Targets Ther. 2018 Apr 20;11:2287-2293. doi: 10.2147/OTT.S140756. eCollection 2018.
10
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells.克拉屈滨治疗多发性硬化症与记忆 B 细胞耗竭有关。
J Neurol. 2018 May;265(5):1199-1209. doi: 10.1007/s00415-018-8830-y. Epub 2018 Mar 17.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Regulatory mechanisms in the synthesis of deoxyribonucleic acid in vitro.体外脱氧核糖核酸合成中的调控机制。
Biochim Biophys Acta. 1960 Jul 15;41:558-9. doi: 10.1016/0006-3002(60)90067-6.
3
ION-EXCHANGE CHROMATOGRAPHY OF NUCLEOTIDES ON POLY-(ETHYLENEIMINE)-CELLULOSE THIN LAYERS.核苷酸在聚(乙烯亚胺)-纤维素薄层上的离子交换色谱法
J Chromatogr. 1964 Oct;16:111-25. doi: 10.1016/s0021-9673(01)82445-6.
4
Further studies on the effect of deoxyadenosine on the accumulation of deoxyadenosine triphosphate and inhibition of deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells in vitro.关于脱氧腺苷对体外培养的艾氏腹水癌细胞中三磷酸脱氧腺苷积累及脱氧核糖核酸合成抑制作用的进一步研究。
Biochim Biophys Acta. 1962 Dec 31;61:885-96. doi: 10.1016/0926-6550(62)90005-1.
5
Purification and properties of adenosine kinase from human tumor cells of type H. Ep. No. 2.来自人H.Ep.No.2型肿瘤细胞的腺苷激酶的纯化及性质
J Biol Chem. 1967 May 10;242(9):1997-2004.
6
Regulation of mammalian deoxyribonucleotide biosynthesis by nucleotides as activators and inhibitors.核苷酸作为激活剂和抑制剂对哺乳动物脱氧核糖核苷酸生物合成的调控。
J Biol Chem. 1966 Oct 25;241(20):4802-9.
7
Rapid determination of nucleoside kinase and nucleotidase activities with tritium-labeled substrates.用氚标记的底物快速测定核苷激酶和核苷酸酶活性。
Anal Biochem. 1969 Apr 4;28(1):192-205. doi: 10.1016/0003-2697(69)90170-5.
8
An extension of the 51Cr-release assay for the estimation of mouse cytotoxins.用于估计小鼠细胞毒素的51铬释放试验的扩展。
Transplantation. 1968 Sep;6(6):761-4. doi: 10.1097/00007890-196809000-00002.
9
Purine nucleoside phosphorylase from human erythroyctes. II. Kinetic analysis and substrate-binding studies.来自人红细胞的嘌呤核苷磷酸化酶。II. 动力学分析和底物结合研究。
J Biol Chem. 1968 Apr 25;243(8):1771-6.
10
Rate-limiting steps in the interconversion of purine ribonucleotides in Ehrlich ascites tumor cells in vitro.体外艾氏腹水瘤细胞中嘌呤核糖核苷酸相互转化的限速步骤。
Cancer Res. 1971 Jul;31(7):985-91.

腺苷脱氨酶缺乏症和嘌呤核苷磷酸化酶缺乏症中的淋巴细胞特异性毒性:核苷激酶的可能作用。

Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).

作者信息

Carson D A, Kaye J, Seegmiller J E

出版信息

Proc Natl Acad Sci U S A. 1977 Dec;74(12):5677-81. doi: 10.1073/pnas.74.12.5677.

DOI:10.1073/pnas.74.12.5677
PMID:202960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC431856/
Abstract

Inherited deficiencies of the enzymes adenosine deaminase (adenosine aminohydrolase; EC 3.5.4.4) and purine nucleoside phosphorylase (purine-nucleoside:orthophosphate ribosyltransferase; EC 2.4.2.1) preferentially interfere with lymphocyte development while sparing most other organ systems. Previous experiments have shown that through the action of specific kinases, nucleosides can be "trapped" intracellularly in the form of 5'-phosphates. We therefore measured the ability of newborn human tissues to phosphorylate adenosine and deoxyadenosine, the substrate of adenosine deaminase, and also inosine, deoxyinosine, guanosine, and deoxyguanosine, the substrates of purine nucleoside phosphorylase. Substantial activities of adenosine kinase were found in all tissues studied, while guanosine and inosine kinases were detected in none. However, the ability to phosphorylate deoxyadenosine, deoxyinosine, and deoxyguanosine was largely confined to lymphocytes. Adenosine deaminase, but not purine nucleoside phosphorylase, showed a similar lymphoid predominance. Other experiments showed that deoxyadenosine, deoxyinosine, and deoxyguanosine were toxic to human lymphoid cells. The toxicity of deoxyadenosine was reversed by the addition of deoxycytidine, but not uridine, to the culture medium. Based upon these and other experiments, we propose that in adenosine deaminase and purine nucleoside phosphorylase deficiency, toxic deoxyribonucleosides produced by many tissues are selectively trapped in lymphocytes by phosphorylating enzyme(s).

摘要

腺苷脱氨酶(腺苷氨基水解酶;EC 3.5.4.4)和嘌呤核苷磷酸化酶(嘌呤核苷:正磷酸核糖基转移酶;EC 2.4.2.1)的遗传性缺陷优先干扰淋巴细胞发育,而对大多数其他器官系统影响较小。先前的实验表明,通过特定激酶的作用,核苷可以以5'-磷酸的形式在细胞内“捕获”。因此,我们测定了新生儿人体组织将腺苷脱氨酶的底物腺苷和脱氧腺苷,以及嘌呤核苷磷酸化酶的底物肌苷、脱氧肌苷、鸟苷和脱氧鸟苷磷酸化的能力。在所研究的所有组织中均发现了腺苷激酶的大量活性,而未检测到鸟苷激酶和肌苷激酶。然而,将脱氧腺苷、脱氧肌苷和脱氧鸟苷磷酸化的能力主要局限于淋巴细胞。腺苷脱氨酶而非嘌呤核苷磷酸化酶也表现出类似的淋巴细胞优势。其他实验表明,脱氧腺苷、脱氧肌苷和脱氧鸟苷对人淋巴细胞有毒性。向培养基中添加脱氧胞苷而非尿苷可逆转脱氧腺苷的毒性。基于这些及其他实验,我们提出,在腺苷脱氨酶和嘌呤核苷磷酸化酶缺乏症中,许多组织产生的有毒脱氧核糖核苷通过磷酸化酶选择性地被困在淋巴细胞中。